ALK-Abelló A/S (OTC:AKBLF – Get Free Report) fell 5.2% on Wednesday . The stock traded as low as $25.13 and last traded at $25.13. 1 shares were traded during trading, a decline of 100% from the average session volume of 670 shares. The stock had previously closed at $26.50.
ALK-Abelló A/S Stock Performance
The firm’s 50 day simple moving average is $24.18 and its 200-day simple moving average is $21.89.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Stories
- Five stocks we like better than ALK-Abelló A/S
- What Are Some of the Best Large-Cap Stocks to Buy?
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Why Invest in High-Yield Dividend Stocks?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- About the Markup Calculator
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
